Global Wealth Strategies & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-938
Closed -$67.4K 175
2026
Q1
$67.4K Buy
938
+827
+745% +$63.7K 0.02% 144
2025
Q4
$8.81K Buy
111
+17
+18% +$1.34K ﹤0.01% 323
2025
Q3
$7.09K Hold
94
﹤0.01% 318
2025
Q2
$6.48K Hold
94
﹤0.01% 248
2025
Q1
$6.37K Hold
94
﹤0.01% 301
2024
Q4
$4.22K Hold
94
﹤0.01% 275
2024
Q3
$5.91K Hold
94
﹤0.01% 229
2024
Q2
$5.55K Hold
94
﹤0.01% 213
2024
Q1
$7.5K Hold
94
﹤0.01% 196
2023
Q4
$7.42K Hold
94
﹤0.01% 185
2023
Q3
$6.56K Hold
94
﹤0.01% 192
2023
Q2
$6.5K Hold
94
﹤0.01% 191
2023
Q1
$6.99K Buy
94
+10
+12% +$839 ﹤0.01% 191
2022
Q4
$7.83K Buy
+84
New +$8.11K ﹤0.01% 174

Other funds holding CVS

Global Wealth Strategies & Associates's CVS Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of CVS Health (CVS) in Q2 2026, closing a stake of 938 shares — an estimated $67.4K sold.

Global Wealth Strategies & Associates first reported a position in CVS in Q4 2022 and held it in 14 quarters. The position peaked at $67.4K in Q1 2026. 733 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 938 CVS Health shares in Q2 2026, an estimated $67.4K.
  • Global Wealth Strategies & Associates first reported a position in CVS Health in Q4 2022 and held it in 14 quarters.
  • Global Wealth Strategies & Associates's CVS Health position peaked at $67.4K in Q1 2026.
  • 733 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.